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doi:10.1016/j.kjms.2011.06.030Abstract Intestinal ischemia/reperfusion (I/R) is a complex phenomenon that causes
destruction of both local and remote tissues. The objective of this study was to investigate
the possible participation of oxidized low-density lipoproteins (oxLDLs) and inducible nitric
oxide synthase (iNOS) expression in renal tissue damage after intestinal I/R. The superior
mesenteric artery was blocked for 30 minutes, followed by 24 hours of reperfusion. At the
end of the reperfusion period, renal tissues were removed; the presence of oxLDL, superoxide
dismutase enzyme activity, malondialdehyde levels, and iNOS expression were evaluated. I/R
resulted in positive oxLDL staining in renal tissue. Compared with control rats, tissue from the
I/R group showed significantly higher malondialdehyde levels and lower superoxide dismutase
enzyme activity. Strong and diffuse iNOS expression was present in the I/R group. Our findings
support the hypothesis that I/R of intestinal tissue results in oxidative and nitrosative stress
and enhances lipid peroxidation in the end organ. These data show that oxLDL accumulates
in rat renal tissue after intestinal I/R. Antioxidant strategies may provide organ protection
in patients with reperfusion injury, at least by affecting interactions with free radicals, nitric
oxide, and oxLDL. This study demonstrates for the first time that oxLDL may play a role in renal
tissue damage after intestinal I/R. Antioxidant strategies may be beneficial for protection from
reperfusion injury.
Copyright ª 2011, Elsevier Taiwan LLC. All rights reserved.t of Pharmacology, Faculty of Medicine, Zonguldak Karaelmas University, Kozlu, Zonguldak 67600,
om (E.Yilmaz Sipahi).
vier Taiwan LLC. All rights reserved.
oxLDL and iNOS expression in renal damage 17Introduction University Research Laboratory). Approval for all experi-Intestinal ischemia/reperfusion (I/R) is a complex phenom-
enon that causes local and remote tissue damage and even
multiple-organ failure. Multiple-organ failure after serious
illness or injury is a major cause of death in the surgical
intensive care unit, and the exact pathophysiology of this
syndrome is still unclear. Intensive care unit mortality directly
correlates with the number of failed organ systems, and
associatedmortality ratesare60e80%dependingonthesource
of obstruction [1]. It was recently suggested that remote organ
injuries are not directly because of exogenous factors, such as
bacteria or toxins, but are largely a consequence of the host’s
own endogenously produced mediators. Cytokines, reactive
oxygen species (ROS), nitric oxide (NO), inducible nitric oxide
synthase (iNOS), and cell adhesion molecules are some medi-
ators that both interact with each other and are involved in
multiple-organ failure syndrome [2e4].
During reperfusion of the intestine, there is an increase in
superoxide production. The absence of effective dis-
mutation of the superoxide anion allows for its rapid reaction
with NO to form the potent reactive nitrogen species per-
oxynitrite, which can react with cellular proteins and lipids
and induce general organ dysfunction.Membrane-associated
polyunsaturated fatty acids are readily attached by ROS in
a process that results in the peroxidation of lipids. Perox-
idation of membrane lipids disrupts membrane fluidity and
cell compartmentation, which can result in cell lysis [2].
Free radicals not only induce oxidative stress in the body
but also initiate lipid peroxidation and maintain oxidation
of low-density lipoproteins (LDLs) [5]. One of the major and
early lipid peroxidation products is oxidized LDL (oxLDL).
Cell-derived reactive oxygen intermediates can affect lipid
metabolism, creating an oxLDL particle that is more
atherogenic than the native LDL. OxLDL leads to foam cell
formation, inflammatory reactions, and cellular hyperplasia
[6e8]. We recently showed for the first time that oxLDL
may play a role in pathologies, including terminal ileum,
liver, and lung damage after intestinal I/R [9]; lung edema
and pulmonary effusion [10]; obstructive jaundice in rats
[11]; and psoriatic skin in psoriatic patients [12]. We also
showed that oxLDL accumulation might play a role in renal
tissue injury after renal I/R [13].
Previous studies have suggested that severe intestinal I/R
injury is accompanied by systemic inflammatory changes and
that the kidney is one of the target organs for effector cells
andmolecules generated fromdistant organ damage [2]. The
effect of intestinal I/R on lipid peroxidation in rat kidney
tissue has not been thoroughly investigated. Accumulating
evidence suggests that renal dysfunction may occur after
intestinal I/R [14e19]. In the present study, we investigated
(1) the presence of oxLDL in renal tissue after intestinal I/R
and (2) the association between oxLDL and iNOS expression
and superoxide dismutase (SOD) activity in renal damage.
Materials and methods
Protocols (rat intestinal I/R model)
Experiments were performed on adult Sprague-Dawley rats
of both sexes weighing 200e230 g (Zonguldak Karaelmasments was obtained from the Zonguldak Karaelmas
University Animal Experiments Local Ethics Committee.
Rats were housed under standard laboratory conditions
with a 12-hour light/dark cycle and were allowed free
access to food and water. During the experimental proce-
dure, the animals were placed in separate cages and kept
at room temperature (22C). The procedures and protocols
of the study were in accord with our institutional guide-
lines, which are parallel to the “Guide for the Care and Use
of Laboratory Animals (US National Institutes of Health,
revised 1985).”
Fourteen animals were divided into two groups of 7 rats
[control group and superior mesenteric artery (SMA)
occlusion group]. The procedure used for inducing SMA
occlusion was performed as previously described [20].
Animals were anesthetized by the administration of intra-
muscular ketamine (90 mg/kg) and xylazine (9 mg/kg). The
abdomen was shaved, and following a midline laparotomy,
the SMA was occluded for 30 minutes with an Aesculap
Yasargil clip (Aesculap Inc., PA 18034, USA) (catalog no: FD
725). Thereafter, flow was restored for 24 hours. Between
surgical interventions, the incision was sutured and covered
with plastic wrap to minimize fluid losses. In the control
group, the SMA was exposed, but not occluded, and animals
were followed for 30 minutes to simulate the ischemic
interval. The reperfusion interval was simulated respec-
tively, and the animals were then subjected to the same
procedures. Animals received normal saline (1 mL) subcu-
taneously immediately after the surgery and were housed
individually and given free access to water.
In the SMA occlusion group, renal tissues were harvested
following reperfusion and used for determining LDL oxida-
tion levels, iNOS expression, malondialdehyde (MDA) levels,
and SOD activity, and for histological examination. The
same analysis procedure was performed in the sham-
operated control group.
Histological examination
For the histopathological examination, tissues were
immersed in 10% formalin and allowed to fix for 2e3 days.
Cross-sections (10 mm) were processed for standard hema-
toxylin and eosin staining. These sections were then
examined via a light microscope and photographed.
MDA measurement
Tissue MDA levels were assessed according to the method
described by Mihara and Uchiyama [21]. Tissues were
homogenized with cold 1.15% KCl to make a 10% homoge-
nate. Phosphoric acid (1%, 3 mL) and thiobarbituric acid
aqueous solution (0.6%, 1 mL) were added to 0.5 mL of the
10% homogenate. The mixture was heated for 45 minutes
on a boiling water bath. After cooling, 4 mL of n-butanol
was added and mixed vigorously. The butanol phase was
separated by centrifugation, and absorbance was measured
at 535 nm and 520 nm on a Shimadzu UV 1601 spectropho-
tometer (Shimadzu, MD 21046, USA). The difference was
used as the thiobarbituric acid value and 1,1,3,3-
tetraethoxypropane was used as a standard. The MDA
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MDA/gram tissue weight).
Tissue protein assay
The protein concentration in the supernatant fraction was
determined using the method of Lowry et al. [22] [Reagent
A, 2% Na2CO3 in 0.1 N NaOH; Reagent B, 0.5% CuSO4$5H2O in
1% sodium or potassium tartrate; Reagent C, alkaline
copper solution; mix 50 mL of Reagent A with 1 mL of
Reagent B; Reagent E, Folin reagent (Folin Ciocalteau
reagent, Sigma Co. (St. Louis, MD 63103, USA))]. Sample
(0.2 mL) and Reagent C (1 mL) were mixed and left standing
for 10 minutes at room temperature. Reagent E (0.10 mL)
was added and the mixture was left standing for 30
minutes. Absorbance was measured at 750 nm using a Shi-
madzu UV 1601 spectrophotometer. Bovine serum albumin
from Sigma was used as the protein standard. The protein
concentration of the supernatant was calculated.
SOD assay
Assay for SOD activity involves the inhibition of nitroblue
tetrazolium (NBT) reduction with xanthine and xanthine
oxidase, which was used as a superoxide generator [23].
Tissues were weighed, and 1.15% KCl was added to make
a 10% homogenate. A total of 2.45 mL SOD measurement
reactive solution (40 mL 0.3 mmol/L xanthine, 20 mL
0.6 mmol/L EDTA, 20 mL 150 mmol/L NBT, 12 mL 400 mmol/
L Na2CO3, and 6 mL 1 g/L bovine serum albumin) was added
to 0.5 mL of the 10% homogenate. At 25C, 0.05 mL
xanthine oxidase reagent was added to each tube at 30-
seconds intervals and incubated for 20 minutes. Xanthine
oxidase reagent was freshly prepared with ice-cold 2 mol/L
NH4SO4, and the final concentration of xanthine oxidase
was 167 U/L. The reaction was terminated by adding 1 mL
of 0.8 mmol/L CuCl2 reagent to each tube at 30-seconds
intervals. The absorbance of each sample was measured at
560 nm on a Shimadzu UV 1601 spectrophotometer. Percent
inhibition was calculated by the following formula:
A blank A sample % inhibitionZ
½ðA blank A sampleÞ=A blank  100%
One unit of SOD was defined as the amount of protein
that inhibits the rate of NBT reduction by 50%. SOD activity
was calculated per milligram tissue protein (unit/milligram
protein).
iNOS immunohistochemical staining method
in tissue
Biopsy materials were fixed in 10% buffered formaldehyde
and 3e5-mm sections were prepared from paraffin-
embedded tissues. After deparaffinization, tissue sections
were boiled in 10 nm citrate buffer at pH 6.0 for 10e20
minutes followed by cooling at room temperature for
20 minutes. These sections were then incubated with
primary antibodies (NOS, iNOS, Ab-1 Rabbit P-Ab Neo-
markers from Biogen Medical (NeoMarkers Inc. Fremont,CA, USA)). All of the samples were immunohistochemically
analyzed using the avidin-biotin complex method.
Immunofluorescent staining method for rat tissue
The presence of oxLDL in the tissue sections of I/R-induced
and sham-operated rats was evaluated using an immuno-
fluorescent staining method. Rat tissues were obtained and
stored at 85C in a deep freeze. Slides were prepared
from frozen tissue biopsy sections, which were cut at 7-mm
thickness. Slides were further divided into two pieces: one
was used for the test and the other for the negative
control. Around 30 mL of human polyclonal anti-oxLDL IgG
solution (IMMCO Diagnostics, New York, NY, USA) was added
to only the test slides as the primary antibody, and the
control slides were treated with the same amount of
phosphate-buffered saline (PBS) solution. After 30 minutes
of incubation in a humid chamber at room temperature,
both the control and test slides were washed with PBS, and
30 mL of fluorescent isothiocyanate-labeled anti-human IgG
was administered as a conjugate substance. For an addi-
tional 30 minutes, the slides were kept and incubated at
room temperature and then washed with the standard PBS
solution. After open-air drying, slides were examined under
fluorescent microscopy at 200 and 400 magnification
(LEICA DMRX, Wetzlar, Germany).
Statistical analysis
Results were expressed as means standard deviation.
Comparisons between groups were made using unpaired
Student t tests. Values of p less than 0.05 were considered
to be statistically significant.
Results
Histological damage following I/R
There was no tissue damage in the control renal (Fig. 1A)
and terminal ileum (Fig. 1B) tissues. Mononuclear cell
infiltration at the tubulus was detected in the I/R group
kidneys (Fig. 1C). Mononuclear cell infiltration was
observed in the villus tips of the lamina propria of the
terminal ileum in the I/R group (Fig. 1D).
The effect of intestinal I/R on renal tissue oxLDL
accumulation
Significant positive immunofluorescent staining was
observed in the I/R group renal tissue (Fig. 2B). Positive
immunofluorescent staining was not present in the control
group (Fig. 2A).
The effect of intestinal I/R on renal tissue MDA
levels and SOD activity
The mean MDA levels and SOD activity of all groups are
shown in Table 1. The tissue MDA level was significantly
higher, and tissue SOD activity was significantly lower, in
the I/R group (p< 0.05).
Figure 1. Representative hematoxylin and eosin staining in (A) renal and (B) terminal ileum tissues of the control group
[hematoxylin and eosin stain (H&E), 20] and (C) renal and (D) terminal ileum tissues of the ischemia/reperfusion group (H&E,
40).
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In the control rat kidney, we observed a mild iNOS immu-
nohistochemical staining reaction only in the proximal
tubulus epithelial cell cytoplasm, whereas staining was not
observed in the glomerular basement membrane (Fig. 3A).
On the other hand, strong iNOS staining reactions were
observed in both the proximal tubulus epithelial cell cyto-
plasm and glomerular basement membrane in the I/R group
kidneys (Fig. 3B). Large magnification of glomerular stain-
ing is shown in Fig. 3B.Discussion
Intestinal I/R induces multiple-organ dysfunction associ-
ated with high rates of mortality, especially in aged
patients [1]. The outcome of intestinal ischemia may be
either acute as a consequence of sudden occlusion of the
mesenteric arterial supply or chronic as a result of
progressive atherosclerosis. Reperfusion injury may
develop in conditions, such as shock and resuscitation, as
well as in many abdominal surgical interventions in which
decreased blood supply is further maintained. Regardless of
whether I/R injury is the patient’s primary pathophysiologic
issue or is secondary to other disease states, progression to
systemic inflammatory response syndrome often ensues
[24], and acute renal failure is a common sequela of the
malignant progression of this syndrome in critically ill
patients.
Mesenteric I/R induces remote organ injury and has been
used as a model for multiple-organ failure syndrome.
Several researchers have shown that hepatic andpulmonary dysfunction may occur after mesenteric I/R
[1,9]. However, the effect of mesenteric I/R on the kidney
has received relatively little attention [14e19]. LaNoue
et al. [25] showed that I/R is associated with a profound
reduction in renal blood flow, and this renal hypoperfusion
is temporally related to decreased renal tissue ATP levels
and acute tubular dysfunction, as manifested by enhanced
sodium loss from the kidney. Our results indicate that I/R in
the mesenteric artery is associated with histopathological
damage in renal tissue. Accumulation of oxLDL, increases in
iNOS expression and MDA levels, and decreases in SOD
activity participated in this damage. These data support
the hypothesis that intestinal I/R results in oxidative and
nitrosative stress and enhances lipid peroxidation in renal
tissue of the rat.
Generation of ROS after reperfusion can result in
oxidative damage of lipids, proteins, and nucleic acids. Our
results demonstrated that the MDA level, which acts as an
indicator of lipid peroxidation, was significantly increased
in renal tissue after intestinal I/R. Lipid peroxidation is
a crucial factor in the propagation of cellular damage from
I/R injury and leads to increased permeability of the
plasma membrane, as well as mitochondrial and lysosomal
membranes.
This is the first study to directly show accumulation of
oxLDL molecules in the renal tissue by fluorescent immu-
nostaining methods after intestinal I/R in rats. Because our
control rat kidneys showed no signs of oxLDL accumulation,
we can conclude that oxLDL might have played an impor-
tant role in I/R-induced renal damage. We know that free
radicals initiate and maintain oxidation of LDL. When
oxidized, unsaturated fatty acids undergo molecular rear-
rangement leading to the generation of peroxy fatty acids.
Table 1 Mean renal malondialdehyde (MDA) concentra-
tion and superoxide dismutase (SOD) activity in the control
and ischemia/reperfusion (I/R) group rat tissues




Control 23.9 8.2 0.69 0.08
I/R 272.6 89.8a 0.40 0.03a
Values are the mean SD.
Intestinal I/R resulted in significantly decreased renal SOD
levels, whereas renal MDA levels were significantly increased.
a p< 0.05 using Student t test
Figure 3. Immunohistochemical localization of inducible
nitric oxide synthase (iNOS) expression in renal tissue of the (A)
control group (indicated by red arrows) (20) and (B)
ischemia/reperfusion (I/R) group (40). (A) Mild positive
staining was obtained in the proximal tubulus epithelial cell
cytoplasm in the control rats (brown staining indicated by
arrows). The glomerular basement membrane of control rats
displayed negative staining for iNOS (indicated by white
arrows). (B) A strong iNOS staining reaction was obtained in the
proximal tubulus epithelial cell cytoplasm and glomerular
basement membrane in the I/R group (brown staining indicated
by arrows). Large magnification of glomerular staining is
shown.
Figure 2. (A) Immunofluorescent staining in renal tissue of
the control group. (B) Significant positive immunofluorescent
staining, which indicates accumulation areas of oxidized low-
density lipoprotein, was observed in the ischemia/reperfu-
sion group (indicated by white arrows) (400).
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redox metals, such as iron and copper, and generate alde-
hydes, such as MDA, 4-hydroxynonenal, and others. We
recently showed that oxLDL accumulates in renal tissue
after renal I/R [13] and in intestinal, lung, and liver tissues
after intestinal I/R [9]. Rothenbach et al. [26] demon-
strated that severe intestinal I/R contributes to down-
regulation of renal function. This decrease in renal function
is caused in part by toxic oxygen metabolites, which occur
in the milieu of altered renal eicosanoid release, reflecting
a decrease in vasodilator and an increase in vasoconstrictor
eicosanoids. Kosaka et al. [27] found that I/R in the kidney
triggers iNOS and lectin-like oxLDL receptor-1 induction.
Lectin-like oxLDL receptor-1 is a newly identified cell
surface major receptor in endothelial cells and is specific
for oxLDL. Reperfusion after organ ischemia accompanies
superoxide generation that accelerates lipid peroxidation
oxLDL and iNOS expression in renal damage 21and oxLDL generation. The absence of effective dis-
mutation of the superoxide anion allows for its rapid
reaction with NO to form the potent reactive nitrogen
species peroxynitrite, which can react with cellular
proteins and lipids (LDL oxidation) and induce general organ
dysfunction [28e30]. Noiri et al. [31] suggested that the
peroxynitrite scavenger ebselen reduces nitrotyrosine
formation in ischemic kidneys and improves the functional
outcome. These observations corroborate our results and
support the hypothesis that reactive nitrogen intermediates
derived from NO may contribute to LDL oxidation in injured
tissues, and that iNOS expression and LDL oxidation are
important participants of I/R injury of end organs, including
the kidney. On the other hand, accumulating evidence
suggests that endothelial activation, dysfunction, and
injury by oxLDL are an early key step in the development of
atherosclerosis and distant organ injury [27,32].
Growing evidence indicates that NO has potent effects
on renal function, including modulation of renal and
glomerular hemodynamics, renin secretion, the tubuloglo-
merular feedback response, and sodium excretion [33].
Despite growing evidence suggesting important roles for NO
in renal function, relatively little is known regarding the
expression and function of iNOS along the normal nephron.
A number of studies have reported that the iNOS protein is
not seen in the kidney under basal conditions [34].
However, recently, the presence of “constitutive” iNOS
mRNA has been demonstrated in a number of nephron
components [35,36]. Morrissey et al. [35] suggested that
there may be tonic influences in the outer medulla of the
normal rat kidney, resulting in the “steady-state” presence
of an iNOS mRNA. Tojo et al. found that a polyclonal anti-
body to an induced form of NOS immunolabeled the
terminal afferent arteriole and thick ascending limb of
Henle of the normal rat kidney but not glomerular mesan-
gial cells [37]. In control rats, we observed a mild iNOS
staining reaction only in the proximal tubulus epithelial cell
cytoplasm but not in the glomerular basement membrane.
In our study, detection of iNOS expression in control rats
supports this concept that iNOS may be “constitutively” and
differentially expressed in specific renal cell types and
participates in the regulation of renal function as previously
proposed [35e39]. The presence of iNOS under basal
conditions may be important in modulating renal functions,
such as regulation of blood flow and salt and water excre-
tion [38]. In our I/R group rats, there was a striking increase
in iNOS expression in proximal tubulus epithelial cell cyto-
plasm when compared with the controls, and the strong
iNOS staining reaction in the glomerular basement
membrane differed from control group rats. These results
suggest that intestinal I/R leads to augmentation of iNOS
expression in various regions of the kidney. The major
question remaining concerns the physiologic function of
iNOS in the normal kidney, particularly in proximal tubulus
epithelial cells.
In conclusion, our study confirms the previously docu-
mented finding that the kidney is one of the target organs
for effector cells and molecules generated from distant
organ injury. This study is the first description of oxLDL
accumulation in renal tissue after 30 minutes ischemia/24
hours reperfusion of SMA in rats. These results support that
I/R injury may extend beyond the ischemic area at risk toinclude injury of remote, nonischemic organs, and that
oxidative and nitrosative stress may play a major role in
tissue damage. Moreover, we believe that accumulation of
oxLDL in tissue has an important role in the events that
result in progressive tissue damage. Augmentation of iNOS
expression may play a role in the progression of inflam-
mation and LDL oxidation. On the other hand, this study
suggests that cellular oxidative stress is a critical step in
reperfusion-mediated injury in renal tissue, for example,
end-organ damage, and that antioxidant strategies may
provide organ protection in patients with reperfusion
damage, at least by affecting interaction with free radicals,
NO, and oxLDL.Acknowledgments
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